Bausch Health to Announce First-Quarter 2023 Results on May 4
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bausch Health Companies (NYSE:BHC) will release its first-quarter financial results on May 4, 2023, at 8:00 a.m. U.S. EDT.
A conference call and live webcast will follow the results announcement, where the company will discuss its business updates. All relevant materials will be provided on the Investor Relations section of Bausch Health's website prior to the call.
Participants can register for the live Q&A session to receive a PIN before the call. The company, committed to enhancing global health, develops products primarily in fields like gastroenterology, neurology, and eye health.
Positive
- Scheduled release of first-quarter results may reflect transparency to investors.
- The live conference call indicates Bausch's commitment to investor engagement and communication.
Negative
- None.
Details
News Market Reaction – BHC
The recorded move for BHC in the trading session of this news was +2.17%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAVAL, QC / ACCESSWIRE / April 13, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release its first-quarter financial results on Thursday, May 4, 2023. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Thursday, May 4, 2023 |
Time: | 8:00 a.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
To participate in the live Q&A session, please register using this link to receive a PIN, which will be sent an hour before the conference call.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX:BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
| Investor Contact: | Media Contact: |
Mark Maico | Kevin Wiggins |
| (877) 281-6642 (toll-free) | (908) 541-3785 |
| (908) 541-2102 |
SOURCE: Bausch Health Companies Inc
View source version on accesswire.com:
https://www.accesswire.com/748968/Bausch-Health-to-Announce-First-Quarter-2023-Results-on-May-4
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.